EUROPE BIOPSY DEVICE MARKET 2019-2027

MARKET OUTLOOK
Triton research predicts that the Europe biopsy device market is expected to rise at a CAGR of 6.66% in terms of revenue over the forecast years of 2019-2027.
Germany, the U.K., France, Spain, Russia, Italy and countries in the rest of Europe together constitute the market for biopsy devices in the European region.
The region will witness the introduction of several new products as there is a high degree of product penetration. People have high awareness of diseases and opt for early diagnosis. Several awareness programs intend to encourage and influence people to undertake regular screening tests to diagnose the exact condition of the disease. Many countries in the region occasionally conduct general mass-screening programs, especially for breast cancer detection. This can significantly cause a hike in the adoption of biopsy devices during the forecast period.
Europe holds the second largest share in the biopsy device market. The need for invasive measures for chronic diseases has boosted the demand for the needle-based segment. Also, developing nations have opened opportunities for European players to expand their market. In addition, to avoid the risks involved with radiological techniques, the need for non-radiological techniques would increase demand for ultrasonic biopsy devices. However, stringent biopsy standards and the complex reimbursement claims are the challenges faced by the market players that need to be overcome.
COMPETITIVE OUTLOOK
The dominant companies in the biopsy market are Ad-Tech Medical Instrument Corp., Planmeca Oy, B. Braun Melsungen AG, Becton, Dickinson, Argon Medical Devices, Inc., QIAGEN N.V., Cardinal Health, Inc., Boston Scientific Corporation, C. R. Bard, Inc. and I.M.S. Internazionale Medico Scientifica SRL.

TABLE OF CONTENTS
1. EUROPEAN BIOPSY DEVICE MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCE OUTLOOK
2.2.1. THREAT OF NEW ENTRANTS
2.2.2. THREAT OF SUBSTITUTES
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. THREAT OF RIVALRY
2.3. VENDOR SCORECARD
2.4. MARKET ATTRACTIVENESS MATRIX
2.5. KEY INSIGHTS
2.6. REGULATIONS OUTLOOK
2.6.1. REGULATION OF BIOPSY DEVICES IN THE EUROPEAN UNION
2.7. PATENTS OUTLOOK
2.8. MARKET DRIVERS
2.8.1. PREVALENCE OF CHRONIC DISEASES ON THE RISE
2.8.2. GROWING PUBLIC KNOWLEDGE OF DISEASE TRANSMISSION
2.8.3. INCREASING DIAGNOSTIC CENTERS
2.9. RESTRAINTS
2.9.1. DEARTH OF SKILLED PROFESSIONALS
2.9.2. REIMBURSEMENT ISSUES
2.10. OPPORTUNITIES
2.10.1. INCREASING INCIDENCE OF LIVER DISEASES
2.11. MARKET CHALLENGES
2.11.1. LIMITED TECHNICAL SKILLS
2.11.2. HIGH COST OF BIOPSY TECHNIQUES
3. BIOPSY DEVICE MARKET OUTLOOK - BY DEVICE TYPE
3.1. BREAST BIOPSY
3.1.1. VACUUM-ASSISTED CORE BIOPSY (VAB)
3.1.2. CORE NEEDLE BIOPSY (CNB)
3.1.3. FINE NEEDLE BIOPSY
3.2. GASTROINTESTINAL (GI) BIOPSY
3.3. SOFT TISSUE BIOPSY NEEDLES
3.4. BRONCHIAL BIOPSY
3.5. GYNECOLOGICAL BIOPSY DEVICE
3.6. ROBOTIC GUIDANCE SYSTEM
3.7. OTHER DEVICES
4. BIOPSY DEVICE MARKET OUTLOOK - BY THERAPEUTIC AREA
4.1. BREAST BIOPSY
4.2. GI BIOPSY
4.3. PROSTATE BIOPSY
4.4. LIVER BIOPSY
4.5. LUNG BIOPSY
4.6. KIDNEY BIOPSY
4.7. GYNECOLOGICAL BIOPSY
4.8. OTHER THERAPEUTIC AREA
5. BIOPSY DEVICE MARKET OUTLOOK - BY DISPLAY TECHNOLOGIES
5.1. MRI-GUIDED BIOPSY
5.2. STEREOTACTIC-GUIDED BIOPSY
5.3. ULTRASOUND-GUIDED BIOPSY
5.4. CT-GUIDED BIOPSY
5.5. OTHER DISPLAY TECHNOLOGIES
6. BIOPSY DEVICE MARKET OUTLOOK - BY END-USER
6.1. DIAGNOSIS CENTER
6.2. HOSPITALS
6.2.1. SPECIALIST
6.2.2. GENERAL
7. BIOPSY DEVICE MARKET - REGIONAL OUTLOOK
7.1. UNITED KINGDOM
7.2. FRANCE
7.3. GERMANY
7.4. ITALY
7.5. SPAIN
7.6. RUSSIA
7.7. REST OF EUROPE
8. COMPANY PROFILES
8.1. AD-TECH MEDICAL INSTRUMENT, CORP.
8.2. ARGON MEDICAL DEVICES, INC.
8.3. B. BRAUN MELSUNGEN AG
8.4. BECTON, DICKINSON
8.5. BOSTON SCIENTIFIC CORPORATION
8.6. CARDINAL HEALTH, INC.
8.7. C. R. BARD, INC.
8.8. I.M.S. INTERNAZIONALE MEDICO SCIENTIFICA SRL
8.9. PLANMECA OY
8.10. QIAGEN N.V.
9. METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY





TABLE LIST
TABLE 1 EUROPE BIOPSY DEVICE MARKET 2019-2027 ($ MILLION)
TABLE 2 IMPLEMENTATION OF BREAST CANCER SCREENING PLATFORMS IN EU BY COUNTRY
TABLE 3 EUROPE BIOPSY DEVICE MARKET BY DEVICE TYPE 2019-2027 ($ MILLION)
TABLE 4 EUROPE BIOPSY DEVICE MARKET IN BREAST BIOPSY DEVICE BY TYPES 2019-2027 ($ MILLION)
TABLE 5 TYPES OF BREAST BIOPSY AND MAMMOGRAPHY EQUIPMENT
TABLE 6 TYPES OF BIOPSY CURETTES
TABLE 7 EUROPE BIOPSY DEVICE MARKET BY THERAPEUTIC AREA 2019-2027 ($ MILLION)
TABLE 8 EUROPE BIOPSY DEVICE MARKET BY DISPLAY TECHNOLOGIES 2019-2027 ($ MILLION)
TABLE 9 EUROPE BIOPSY DEVICE MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 10 COMMON AREAS OF BIOPSY
TABLE 11 EUROPE BIOPSY DEVICE MARKET BY COUNTRIES 2019-2027 ($ MILLION)






FIGURES LIST
FIGURE 1 SHARES OF THE EUROPEAN PATENT HOLDER (%)
FIGURE 2 EUROPE BIOPSY DEVICE MARKET IN BREAST BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 3 EUROPE BREAST BIOPSY DEVICE MARKET IN VACUUM-ASSISTED CORE BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 4 EUROPE BREAST BIOPSY DEVICE MARKET IN CORE NEEDLE BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 5 EUROPE BREAST BIOPSY DEVICE MARKET IN FINE NEEDLE BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 6 EUROPE BIOPSY DEVICE MARKET IN GI BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 7 EUROPE BIOPSY DEVICE MARKET IN SOFT TISSUE BIOPSY NEEDLES MARKET 2019-2027 ($ MILLION)
FIGURE 8 EUROPE BIOPSY DEVICE MARKET IN BRONCHIAL BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 9 EUROPE BIOPSY DEVICE MARKET IN GYNECOLOGICAL BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 10 EUROPE BIOPSY DEVICE MARKET IN ROBOTIC GUIDANCE SYSTEM 2019-2027 ($ MILLION)
FIGURE 11 EUROPE BIOPSY DEVICE MARKET IN OTHER BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 12 EUROPE BIOPSY DEVICE MARKET IN BREAST BIOPSY THERAPEUTIC AREA 2019-2027 ($ MILLION)
FIGURE 13 EUROPE BIOPSY DEVICE MARKET IN GI BIOPSY 2019-2027 ($ MILLION)
FIGURE 14 EUROPE BIOPSY DEVICE MARKET IN PROSTATE BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 15 EUROPE BIOPSY DEVICE MARKET IN LIVER BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 16 EUROPE BIOPSY DEVICE MARKET IN LUNG BIOPSY DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 17 EUROPE BIOPSY DEVICE MARKET IN KIDNEY BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 18 EUROPE BIOPSY DEVICE MARKET IN GYNECOLOGICAL BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 19 EUROPE BIOPSY DEVICE MARKET IN OTHER THERAPEUTIC AREA 2019-2027 ($ MILLION)
FIGURE 20 EUROPE BIOPSY DEVICE MARKET IN MRI-GUIDED BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 21 EUROPE BIOPSY DEVICE MARKET IN STEREOTACTIC BREAST BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 22 EUROPE BIOPSY DEVICE MARKET IN ULTRASOUND-GUIDED BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 23 EUROPE BIOPSY DEVICE MARKET IN CT-GUIDED BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 24 EUROPE BIOPSY DEVICE MARKET IN OTHER DISPLAY TECHNOLOGIES BIOPSY DEVICE 2019-2027 ($ MILLION)
FIGURE 25 EUROPE BIOPSY DEVICE MARKET IN DIAGNOSIS CENTER 2019-2027 ($ MILLION)
FIGURE 26 EUROPE BIOPSY DEVICE MARKET IN HOSPITAL 2019-2027 ($ MILLION)
FIGURE 27 EUROPE HOSPITAL MARKET IN SPECIALIST HOSPITAL 2019-2027 ($ MILLION)
FIGURE 28 EUROPE HOSPITAL MARKET IN GENERAL HOSPITAL 2019-2027 ($ MILLION)
FIGURE 29 EUROPE BIOPSY DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 30 UNITED KINGDOM BIOPSY DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 31 FRANCE BIOPSY DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 32 GERMANY BIOPSY DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 33 ITALY BIOPSY DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 34 SPAIN BIOPSY DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 35 RUSSIA BIOPSY DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 36 REST OF EUROPE BIOPSY DEVICE MARKET 2019-2027 ($ MILLION)